These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37379505)

  • 1. Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility.
    Goodin DS; Khankhanian P; Gourraud PA; Vince N
    PLoS One; 2023; 18(6):e0285599. PubMed ID: 37379505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature of genetic and environmental susceptibility to multiple sclerosis.
    Goodin DS; Khankhanian P; Gourraud PA; Vince N
    PLoS One; 2021; 16(3):e0246157. PubMed ID: 33750973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of multiple sclerosis: genetic, environmental and random mechanisms.
    Goodin DS
    J Neurol Neurosurg Psychiatry; 2024 Jul; ():. PubMed ID: 38960584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
    Goodin DS
    BMC Neurol; 2016 Apr; 16():56. PubMed ID: 27117889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
    Goodin DS
    PLoS One; 2012; 7(12):e47875. PubMed ID: 23272039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The causal cascade to multiple sclerosis: a model for MS pathogenesis.
    Goodin DS
    PLoS One; 2009; 4(2):e4565. PubMed ID: 19242548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of multiple sclerosis: insights to a causal cascade.
    Goodin DS
    Handb Clin Neurol; 2016; 138():173-206. PubMed ID: 27637959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic basis of multiple sclerosis: a model for MS susceptibility.
    Goodin DS
    BMC Neurol; 2010 Oct; 10():101. PubMed ID: 21029420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and birth order: a longitudinal cohort study.
    Sadovnick AD; Yee IM; Ebers GC;
    Lancet Neurol; 2005 Oct; 4(10):611-7. PubMed ID: 16168929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group.
    Ebers GC; Sadovnick AD; Risch NJ
    Nature; 1995 Sep; 377(6545):150-1. PubMed ID: 7675080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of environmental factors in multiple sclerosis: Genes, environment and the interactions thereof in the etiology of multiple sclerosis.
    Sadovnick D
    Rev Neurol (Paris); 2019 Dec; 175(10):593-596. PubMed ID: 31519302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in multiple sclerosis epidemiology and treatment response.
    Magyari M
    Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Pérez Benítez CI; Vicente B; Zlotnick C; Kohn R; Johnson J; Valdivia S; Rioseco P
    Salud Ment (Mex); 2009 Jan; 32(2):145-153. PubMed ID: 21113425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy does not modify the risk of MS in genetically susceptible women.
    Adams CJ; Wu SL; Shao X; Bradshaw PT; Gonzales E; Smith JB; Xiang AH; Bellesis KH; Chinn T; Bos SD; Wendel-Haga M; Olsson T; Kockum I; Langer-Gould AM; Schaefer C; Alfredsson L; Barcellos LF
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 33037103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic and environmental factors in multiple sclerosis].
    Fernández O
    Rev Neurol; 2000 May 16-31; 30(10):964-7. PubMed ID: 10919196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating machine learning approaches to assess putative environmental risk factors for multiple sclerosis.
    Mowry EM; Hedström AK; Gianfrancesco MA; Shao X; Schaefer CA; Shen L; Bellesis KH; Briggs FBS; Olsson T; Alfredsson L; Barcellos LF
    Mult Scler Relat Disord; 2018 Aug; 24():135-141. PubMed ID: 30005356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment.
    Dyment DA; Yee IM; Ebers GC; Sadovnick AD;
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):258-9. PubMed ID: 16421134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parental transmission of MS in a population-based Canadian cohort.
    Herrera BM; Ramagopalan SV; Orton S; Chao MJ; Yee IM; Sadovnick AD; Ebers GC
    Neurology; 2007 Sep; 69(12):1208-12. PubMed ID: 17596583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.
    Salehi Z; Almasi-Hashiani A; Sahraian MA; Eskandarieh S
    Mult Scler Relat Disord; 2020 Aug; 43():102178. PubMed ID: 32417663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.